T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Xometry
XMTR
$5.45B
| $298M | 0.05% |
5,252,278
-1,428,078
| -21% | -$66.7M |
|
302
Corteva
CTVA
$50.1B
| $296M | 0.05% |
5,179,066
-3,337,255
| -39% | -$194M |
|
303
Procore
PCOR
$8.93B
| $292M | 0.05% |
5,899,536
+27,715
| +0.5% | +$1.49M |
|
|
HCP
304
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $292M | 0.05% |
9,067,239
+2,606,710
| +40% | +$90M |
|
305
Teleflex
TFX
$5.77B
| $292M | 0.05% |
1,448,497
-6,886,649
| -83% | -$1.65B |
|
306
Brown & Brown
BRO
$23.8B
| $285M | 0.05% |
4,713,168
-642,364
| -12% | -$40.4M |
|
307
Ralph Lauren
RL
$23B
| $282M | 0.05% |
3,320,091
+406,758
| +14% | +$38.3M |
|
308
Mettler-Toledo International
MTD
$28.5B
| $280M | 0.05% |
258,347
+52,603
| +26% | +$65.4M |
|
309
Mattel
MAT
$4.21B
| $277M | 0.05% |
14,607,025
+783,032
| +6% | +$17.5M |
|
310
Revvity
RVTY
$13.1B
| $272M | 0.04% |
2,262,938
-12,751,870
| -85% | -$1.8B |
|
311
Ulta Beauty
ULTA
$22.1B
| $272M | 0.04% |
678,285
+313,579
| +86% | +$126M |
|
312
Caterpillar
CAT
$396B
| $271M | 0.04% |
1,649,261
-3,522
| -0.2% | -$643K |
|
313
General Motors
GM
$75.9B
| $270M | 0.04% |
8,418,311
-1,038,612
| -11% | -$38.1M |
|
|
SRCL
314
DELISTED
Stericycle Inc
SRCL
| $269M | 0.04% |
6,386,104
-4,084,650
| -39% | -$197M |
|
315
Peloton Interactive
PTON
$2.37B
| $269M | 0.04% |
38,764,584
-6,022,869
| -13% | -$61.2M |
|
316
CMS Energy
CMS
$22.1B
| $266M | 0.04% |
4,573,050
-7,545,981
| -62% | -$508M |
|
|
BPMC
317
DELISTED
Blueprint Medicines
BPMC
| $266M | 0.04% |
4,031,811
-1,599,876
| -28% | -$103M |
|
318
Webster Financial
WBS
$12.8B
| $260M | 0.04% |
5,753,283
-990,187
| -15% | -$45.8M |
|
319
Amgen
AMGN
$226B
| $258M | 0.04% |
1,143,557
-730,736
| -39% | -$177M |
|
320
Pinduoduo
PDD
$120B
| $257M | 0.04% |
4,100,288
+157,842
| +4% | +$9.18M |
|
321
Alexandria Real Estate Equities
ARE
$8.33B
| $254M | 0.04% |
1,811,278
-48,831
| -3% | -$7.49M |
|
322
Essex Property Trust
ESS
$18.5B
| $253M | 0.04% |
1,046,140
-40,561
| -4% | -$11M |
|
323
Darling Ingredients
DAR
$10.2B
| $252M | 0.04% |
3,811,167
-1,809,778
| -32% | -$126M |
|
324
Illinois Tool Works
ITW
$82.7B
| $251M | 0.04% |
1,385,680
-1,420,151
| -51% | -$280M |
|
325
Halliburton
HAL
$27.4B
| $246M | 0.04% |
10,000,162
-1,629,204
| -14% | -$46.6M |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.